PHILOGEN ANNOUNCES NEW COLLABORATION WITH JANSSEN to DISCOVER SMALL MOLECULE THERAPEUTICS

Under the terms of the agreement, Philochem will work with Janssen to apply its proprietary DNA-encoded chemical library technology platform, seeking to identify small molecule compounds that bind to specific targets. Janssen may exercise the options to use these identified ligands as candidates for further drug discovery and development activities. Read More